Currently, both Democratic and Republican politicians are focusing on combating health care conglomerates that they believe drive up costs and limit access. The health care industry’s significant economic influence often makes it challenging for politicians to enforce strict regulations. As health care costs remain a critical issue in the 2024 presidential race, both Harris and Walz’s previous actions suggest they might continue to challenge corporate power, although how forcefully remains uncertain. Richard Scheffler, quoted in the article, explains that health care conglomerates who are using their market power to raise prices should be concerned under a Harris-Walz administration.
Read the full Washington Post article here.